London
28 °C
Manchester
25 °C
Glasgow
26 °C
Dublin
16 °C
Belfast
13 °C
Washington
20 °C
Denver
6 °C
Atlanta
19 °C
Dallas
17 °C
Houston Texas
25 °C
New Orleans
23 °C
El Paso
14 °C
Phoenix
20 °C
Los Angeles
14 °C
San Diego
14 °C
San Francisco
11 °C
Chicago
12 °C
Minneapolis
13 °C
Seattle
7 °C
Portland
6 °C
Salt Lake City
8 °C
Las Vegas
21 °C
Miami
26 °C
Jacksonville
24 °C
San Antonio
24 °C
Bermuda
20 °C
Nassau
16 °C
Iqaluit
-4 °C
Yellowknife
-7 °C
Anchorage
5 °C
Fairbanks
1 °C
Barrow
-17 °C
Calgary
5 °C
Edmonton
21 °C
Winnipeg
5 °C
Goose Bay
9 °C
Halifax
12 °C
Boston
13 °C
Ottawa
8 °C
Toronto
8 °C
Detroit
10 °C
Cleveland
18 °C
New York
16 °C
Baltimore
20 °C
Philadelphia
17 °C
Nuuk (Godthåb)
-3 °C
Hong Kong
26 °C
Singapore
27 °C
Melbourne
25 °C
Canberra
8 °C
Adelaide
13 °C
Darwin
26 °C
Perth
20 °C
Fort Worth
17 °C
Honolulu
24 °C
Sydney
13 °C
Johannesburg
22 °C
Dubai
37 °C
Mumbai
30 °C
Zürich
26 °C
Tokyo
18 °C
Seoul
12 °C
Delhi
35 °C
Beijing
16 °C
Riyadh
38 °C
Prague
23 °C
Pennsylvania
17 °C
Valletta
27 °C
Manama
35 °C
Warsaw
19 °C
TAMPA, FLORIDA / ACCESS Newswire / March 3, 2025 / CTT Pharmaceutical Holdings, Inc. (OTC PINK:CTTH) is expecting notification this week for uplisting status to the OTCQB. CTT will notify shareholders as more news becomes available.
CTT Pharma - 813-606-0060
SOURCE: CTT Pharmaceutical Holdings, Inc.
View the original press release on ACCESS Newswire
Y.Walker--SMC
